CIPLA LTD vs GUJARAT KIDNEY N SUP SP L
A side-by-side comparison of CIPLA LTD (CIPLA) and GUJARAT KIDNEY N SUP SP L (GKSL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, CIPLA LTD leads CIPLA vs GKSL on 10 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation40
- Profitability22
- Growth· not comparable—
- Size & financial health40
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
CIPLA takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
CIPLA takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
- − ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]
- + ["Company is expected to give good quarter"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has high debtors of 172 days.", "Working capital days have increased from 55.7 days to 91.1 days"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.